---
title: "Kunlun released its performance for the first three quarters, with a net loss attributable to the parent company of 665 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263380433.md"
description: "According to the Zhitong Finance APP, Kunlun released its third-quarter report for 2025, stating that the company's operating revenue for the first three quarters was 5.805 billion yuan, a year-on-year increase of 51.63%. The net loss attributable to shareholders of the listed company was 665 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 674 million yuan. The basic loss per share was 0.54 yuan"
datetime: "2025-10-29T22:01:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263380433.md)
  - [en](https://longbridge.com/en/news/263380433.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263380433.md)
generator: "portal-rs"
---

# Kunlun released its performance for the first three quarters, with a net loss attributable to the parent company of 665 million yuan

According to the Zhitong Finance APP, Kunlun (300418.SZ) released its third-quarter report for 2025, showing that the company's operating revenue for the first three quarters was 5.805 billion yuan, a year-on-year increase of 51.63%. The net loss attributable to shareholders of the listed company was 665 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 674 million yuan. The basic loss per share was 0.54 yuan

### Related Stocks

- [300418.CN](https://longbridge.com/en/quote/300418.CN.md)

## Related News & Research

- [Bill Ackman Loves This Dividend Stock, But You Should Give It a Pass](https://longbridge.com/en/news/296545633.md)
- [BIG Impact-backed Letara raises JPY 26 billion in pre-Series A round](https://longbridge.com/en/news/296584540.md)
- [Thinking about buying SpaceX? These 2 stocks should be better bets](https://longbridge.com/en/news/296265483.md)
- [PXT: Production guidance nearly doubles for H2 2026, driven by acquisitions and exploration success](https://longbridge.com/en/news/296393798.md)
- [PMGC unit NorthStrive Biosciences files US patents for EL-22, EL-32 to curb microgravity muscle loss](https://longbridge.com/en/news/296624370.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**